Patents Assigned to GALDERMA RESEARCH & DEVELOPEMENT
  • Publication number: 20210355067
    Abstract: The invention relates to new compounds of the general formula (I): as well as the use thereof in pharmaceutical compositions intended for use in human or veterinary medicine (dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders, in particular), or in the use of cosmetic compositions.
    Type: Application
    Filed: May 3, 2021
    Publication date: November 18, 2021
    Applicant: GALDERMA RESEARCH & DEVELOPEMENT
    Inventor: Thibaud PORTAL
  • Publication number: 20140221648
    Abstract: A method is described for using IL-12R 1/IL-23R, CCR6, BATF, AHR, STAT3, IRF4 crucial actors in Th17 cells differentiation as markers for acne. Also described are method of their use to diagnose acne, to screen inhibitors of Th17 differentiation. In particular, methods are described for inhibiting IL12R 1/IL-23R, CCR6, BATF, AHR, STAT3, IRF4 and the use of these screened inhibitors in acne treatment.
    Type: Application
    Filed: June 25, 2012
    Publication date: August 7, 2014
    Applicant: GALDERMA RESEARCH & DEVELOPEMENT
    Inventor: Isabelle Carlavan